{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Rockford",
      "address_1": "4901 Hiawatha Dr",
      "reason_for_recall": "Presence of Particulate Matter",
      "address_2": "",
      "product_quantity": "a) 35,197 vials; b) 21,302 vials",
      "code_info": "Lot #: a) 7801396, 7801398, 7801401, 7801406, Exp 08/16; 7801427, Exp 09/16; b) 7801089, 7801084, Exp 07/15; 7801110, Exp 08/15",
      "center_classification_date": "20150814",
      "distribution_pattern": "Nationwide and Puerto Rico",
      "state": "IL",
      "product_description": "Gemcitabine for Injection, USP, 200 mg*/vial, Lyophilized powder in a Single-Use Vial, Rx only, labeled as a) Manufactured for: Mylan Institutional LLC, Rockford, IL  61103, Made in India, NDC 67457-464-20, UPC 3 67457 46420 6; and b) Distributed by Pfizer Labs, Division of Pfizer Inc, New York, NY  10017, Made in India, NDC 0069-3857-10, UPC 3 00693 85710 4.",
      "report_date": "20150826",
      "classification": "Class I",
      "openfda": {},
      "recalling_firm": "Mylan Institutional LLC",
      "recall_number": "D-1332-2015",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "71004",
      "termination_date": "20160520",
      "more_code_info": "",
      "recall_initiation_date": "20150323",
      "postal_code": "61103-1287",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}